OptimizeRx Affirms FY2026 Sales Guidance
OptimizeRx affirms FY2026 sales outlook of $95-100 million
OptimizeRx (NASDAQ: OPRX ) affirms FY2026 sales outlook from $95.000 million-$100.000 million to $95.000 million-$100.000 million vs $97.427 million estimate.